Cargando…
Pharmacological Targeting of Phosphoinositide Lipid Kinases and Phosphatases in the Immune System: Success, Disappointment, and New Opportunities
The predominant expression of the γ and δ isoforms of PI3K in cells of hematopoietic lineage prompted speculation that inhibitors of these isoforms could offer opportunities for selective targeting of PI3K in the immune system in a range of immune-related pathologies. While there has been some succe...
Autores principales: | Blunt, Matthew D., Ward, Stephen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410520/ https://www.ncbi.nlm.nih.gov/pubmed/22876243 http://dx.doi.org/10.3389/fimmu.2012.00226 |
Ejemplares similares
-
Targeting Integrins for Cancer Therapy - Disappointments and Opportunities
por: Bergonzini, Cecilia, et al.
Publicado: (2022) -
Breast Cancer Vaccines: Disappointing or Promising?
por: Zhu, Si-Yuan, et al.
Publicado: (2022) -
Disease Evolution and Response to Rapamycin in Activated Phosphoinositide
3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated
Phosphoinositide 3-Kinase δ Syndrome Registry
por: Maccari, Maria Elena, et al.
Publicado: (2018) -
Dysregulation of Phosphoinositide 5-Phosphatases and Phosphoinositides in Alzheimer's Disease
por: Ando, Kunie, et al.
Publicado: (2021) -
Dimebon disappointment
por: Jones, Roy W
Publicado: (2010)